Are FDA’s New Revised “Rules” for Distribution of Off-label Reprints Too Limiting?

Please take 2 minutes to answer a few short questions relating to the FDA's Revised Draft Guidance for Industry on Distributing Scientific and Medical Publications on Unapproved New Uses—Recommended Practices.

Should Pharma Hire Online “Patient Opinion Leaders”?

This survey asks YOUR opinion about best practices that you think should govern pharma's collaboration with online

Pharma Marketing Survey: Search Engine Marketing

This survey asks your opinion on whether or not paid inclusion should be used by pharmaceutical marketers and under what conditions.

Disease Mongering: Real or Fantasy?

Disease mongering is a term used to describe a perceived attempt by pharmaceutical companies to promote public awareness of (frequently harmless) conditions or diseases with the aim of increasing sales of medication.

Should Free Drug Samples Be Banned?

While the new PhRMA Code on Interactions with Healthcare Professionals bans free pens and lunches, it doesn't apply to samples. Should free drug samples also be banned? Take our survey and give us your opinion.

What Do You Think of FDA’s Recent Regulatory Actions?

This survey asks you to express your opinion anonymously about FDA's letter to Novartis regarding its Tasigna Facebook Share button and other recent warnings sent to pharmaceutical companies, especially with regard to social media and search engine marketing.

What’s Your Social Media Implementation Plan?

Before you find yourself in a social media crisis, you should have a social media implementation plan. But what are the action items for implementing your plan? This survey presents a number of actions that may be appropriate and seeks your input on how important these or other items might be in developing a plan.

Should FDA Be Reformed?

In the wake of the VIOXX withdrawal, critics have suggested that FDA needs to reform how it regulates the drug industry. Many suggestions for reform have been suggested. We present a few of them here. Let us know what you think of these suggestions or if the FDA requires no reform at all!

Use of Patient Testimonials in DTC & Social Media Advertising Survey

Recently, pharma companies appear to be using more patient testimonials in their DTC (direct-to-consumer) broadcast and social media advertising. This survey asks your opinion of this practice, including what the benefits may be, the regulatory issues, and how it may evolve, especially with regard to use of social media.

The Value of Social, Mobile, & Gaming Technologies for Improving Adherence

This survey is designed to inform the discussion on the pros and cons of how Social, Mobile, & Gaming Technologies technologies drive patient engagement and what value they have in solving the long-standing medication adherence problem.
- Advertisement -